Anti-Tim3 RMT3-23 exhibited anti-tumor efficiency in mice bearing MC38 colon adenocarcinoma, CT26 colon adenocarcinoma, and WTMCA2 fibrosarcoma as well. Here, HAVCR2 is linked to colon adenocarcinoma.